Reuters logo
BRIEF-Shandong Longlive Bio-Technology sees H1 FY 2017 net profit up 30 pct to 75 pct
April 28, 2017 / 12:20 PM / 7 months ago

BRIEF-Shandong Longlive Bio-Technology sees H1 FY 2017 net profit up 30 pct to 75 pct

April 28(Reuters) - Shandong Longlive Bio-Technology Co Ltd

* Sees H1 FY 2017 net profit to increase by 30 percent to 75 percent, or to be 58.0 million yuan to 78.1 million yuan

* Says H1 FY 2016 net profit was 44.6 million yuan

* Says inclusion of two units is the main reason for the forecast

Source text in Chinese: goo.gl/BKf8hb

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below